State Street Corp Immuno Gen, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $18.4 Million - $44.2 Million	-1,476,181 Reduced 15.45%	8,075,671 $239 Million
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $22.7 Million - $32 Million	1,612,938 Added 20.32%	9,551,852 $152 Million
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $34.3 Million - $183 Million	-9,138,044 Reduced 53.51%	7,938,914 $150 Million
Q1 2023 May 15, 2023	SELL	$3.67 - $4.92 $1.58 Million - $2.12 Million	-431,155 Reduced 2.46%	17,076,958 $65.6 Million
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $13.3 Million - $18.4 Million	2,913,240 Added 19.96%	17,508,113 $86.8 Million
Q3 2022 Nov 15, 2022	SELL	$4.48 - $6.47 $16.1 Million - $23.3 Million	-3,604,681 Reduced 19.81%	14,594,873 $69.8 Million
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $14.2 Million - $25.9 Million	4,492,165 Added 32.77%	18,199,554 $81.9 Million
Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $24 Million - $42.2 Million	5,638,822 Added 69.89%	13,707,389 $65.2 Million
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $4.74 Million - $7.48 Million	-997,290 Reduced 11.0%	8,068,567 $59.9 Million
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $8.3 Million - $10.9 Million	-1,654,074 Reduced 15.43%	9,065,857 $51.4 Million
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $9.82 Million - $14.6 Million	1,696,452 Added 18.8%	10,719,931 $70.6 Million
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $1.43 Million - $2.31 Million	219,638 Added 2.49%	9,023,479 $73.1 Million
Q4 2020 Feb 16, 2021	SELL	$3.7 - $7.66 $592,610 - $1.23 Million	-160,165 Reduced 1.79%	8,803,841 $56.8 Million
Q3 2020 Nov 10, 2020	SELL	$3.45 - $4.89 $756,585 - $1.07 Million	-219,300 Reduced 2.39%	8,964,006 $32.3 Million
Q2 2020 Aug 14, 2020	BUY	$3.32 - $5.34 $11.5 Million - $18.5 Million	3,457,441 Added 60.38%	9,183,306 $42.2 Million
Q1 2020 May 11, 2020	BUY	$2.12 - $6.8 $12.1 Million - $38.9 Million	5,725,865 New	5,725,865 $19.5 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account